Dana Senaha shares family experience with new pancreatic cancer drug
Dana Senaha described her husband’s participation in the clinical trial for daraxonrasib during a presentation at the STAT Summit in Boston. The drug represents a significant advance in treating pancreatic cancer, a disease that is notoriously difficult to manage. While clinical data indicates the medication extends life, Senaha noted that these figures do not capture the personal impact on patients or the substantial resources required to access new therapies. Bobby Senaha’s cancer had stopped responding to standard chemotherapy, prompting the family to travel to California and Texas in search of treatment. The family eventually returned to Hawaii, where Bobby Senaha died on Aug. 25, 2024. Senaha’s account highlights the human dimension of drug approval processes and the logistical challenges faced by families seeking advanced medical care.
Dana Senaha described her husband’s participation in the clinical trial for daraxonrasib during a presentation at the STAT Summit in Boston. The drug represents a significant advance in treating pancreatic cancer, a disease that is notoriously difficult to manage. While clinical data indicates the medication extends life, Senaha noted that these figures do not capture the personal impact on patients or the substantial resources required to access new therapies. Bobby Senaha’s cancer had stopped responding to standard chemotherapy, prompting the family to travel to California and Texas in search of treatment. The family eventually returned to Hawaii, where Bobby Senaha died on Aug. 25, 2024. Senaha’s account highlights the human dimension of drug approval processes and the logistical challenges faced by families seeking advanced medical care.